{
    "2021-03-08": [
        [
            {
                "time": "",
                "original_text": "平安证券----生物医药行业周报：《政府工作报告》发布，将进一步深化医药卫生体制改革【行业研究】",
                "features": {
                    "keywords": [
                        "政府工作报告",
                        "医药卫生体制改革",
                        "生物医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股普遍调整，健帆生物、凯莱英、广联达、国瓷材料、泰格医药领跌",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "健帆生物",
                        "凯莱英",
                        "广联达",
                        "国瓷材料",
                        "泰格医药"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业：调整是布局良机 重点关注新冠疫苗加速接种带来的投资机会",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "新冠疫苗",
                        "接种",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[银河医药孟令伟/刘晖】行业深度丨小核酸时代终将到来，优质赛道如何掘金？",
                "features": {
                    "keywords": [
                        "银河医药",
                        "小核酸时代",
                        "优质赛道",
                        "掘金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：创新药企商业化能力的再思考",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药企",
                        "商业化能力"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}